European firms on Wednesday accused Chinese solar panel makers of dodging hundreds of millions of euros in import duties and called on the European Union to launch an investigation.
The complaint threatens to spark a new flare-up in a long-running row on the issue that Brussels and Beijing only recently managed to damp down.
“Up to 30 per cent of Chinese solar imports bypass EU import measures through fraudulent circumvention,” industry group EU ProSun said.
“European industry has already been devastated by illegal Chinese practices and the EU and European governments have lost substantial tax revenues at a time of great need,” group spokesman Milan Nitzschke said in a statement.
EU ProSun said China was exporting solar modules and cells via Taiwan and Malaysia, passing them off as locally made to avoid EU levies, and it had lodged an official request with the European Commission for an investigation.
The filing threatens to reopen a rift between the EU and China after a deal late 2013 set a minimum price and a cap on European imports of solar panels from China until the end of 2015.
Full content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas